AAA
JNJ icon

Andrews Advisory Associates’s Johnson & Johnson JNJ Stock Holding History

Andrews Advisory Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
6,499
-260
-4% -$60.6K 0.79% 26
2026
Q1 		$1.65M Sell
6,759
-730
-10% -$170K 0.87% 21
2025
Q4 		$1.55M Buy
+7,489
New +$1.48M 0.82% 24

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Andrews Advisory Associates's JNJ Position: Q2 2026 in Review

Andrews Advisory Associates reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, selling an estimated $60.6K and leaving 6,499 shares worth $1.65M. The position accounts for 0.79% of the portfolio, ranked #26.

Andrews Advisory Associates first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.65M in Q1 2026. 4,669 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Andrews Advisory Associates held 6,499 shares of Johnson & Johnson worth $1.65M as of Q2 2026.
  • Andrews Advisory Associates sold 260 Johnson & Johnson shares in Q2 2026, an estimated $60.6K.
  • Johnson & Johnson made up 0.79% of Andrews Advisory Associates's portfolio in Q2 2026, its #26 holding.
  • Andrews Advisory Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Andrews Advisory Associates's Johnson & Johnson position peaked at $1.65M in Q1 2026.
  • 4,669 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Andrews Advisory Associates's 13F filing for Q2 2026, filed 17 Jul 2026.